Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Re-examining the Meis Trial for Evidence of False-Positive Results
Baha Sibai
, George R. Saade
, Anita F. Das
Obstetrics & Gynecology
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Re-examining the Meis Trial for Evidence of False-Positive Results'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
False-positive Results
100%
Meis
100%
Progestin
83%
17α-hydroxyprogesterone Caproate
66%
United States
50%
Preterm Birth Rate
33%
Public Health
16%
High Risk
16%
Pregnant Women
16%
Maternal-fetal Medicine
16%
Children's Health
16%
Human Development
16%
Health Development
16%
Test-negative Design
16%
Kennedy
16%
U.S. Food
16%
Recurrent Preterm Birth
16%
Conditional Approval
16%
Recurrent Preterm Delivery
16%
Medicine and Dentistry
False Positive Result
100%
Gestagen
100%
Premature Labor
80%
Hydroxyprogesterone Caproate
80%
Birth Rate
40%
Public Health
20%
Perinatology
20%
Child Health
20%
False Negative Result
20%
Hydroxyprogesterone
20%
Human Development
20%
Preterm Delivery
20%
Nursing and Health Professions
False Positive Result
100%
Gestagen
100%
Premature Labor
80%
Hydroxyprogesterone Caproate
80%
Food and Drug Administration
40%
Birth Rate
40%
National Health Organization
20%
False Negative Result
20%
Hydroxyprogesterone
20%
Public Health
20%
Pharmacology, Toxicology and Pharmaceutical Science
Progestin
100%
Premature Labor
80%
Hydroxyprogesterone Caproate
80%
Hydroxyprogesterone
20%
Neuroscience
Progestin
100%
Hydroxyprogesterone Caproate
80%
17-Hydroxyprogesterone
20%
Chemistry
Progestin
100%
Hydroxyprogesterone Caproate
80%
Assert
20%